InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
17,017.20
(
0.93%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.96
(
0.50%
)
Bitcoin
57,651.19
(
-1.01%
)
Post# of 4273
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: biotech_researcher post# 2689

Tuesday, 07/04/2017 8:06:29 AM

Tuesday, July 04, 2017 8:06:29 AM

Post# of 4273
Catalysts
1 drug sales updates
2 IBS-C approval

Potential Catalysts
1 partnership/merger/buyout
2 (unlikely) hostile takeover
3 (unlikely) activist investor intervention
4 further dilution

FWIW:
from drugs.com

Linzess User Ratings

10 41% (94)

9 16% (36)

8 8% (18)

7 5% (11)

6 6% (13)

5 4% (7)

4 4% (8)

3 5% (10)

2 4% (7)

1 13% (29)

Trulance User Ratings

10 63% (10)

9 19% (3)

8 0% (0)

7 0% (0)

6 0% (0)

5 7% (1)

4 0% (0)

3 7% (1)

2 0% (0)

1 7% (1)

It's really early, but there are not as many tolerability complaints as I recall with Linzess out of the gate.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up